
glucura supports the therapy of Type 2 Diabetes Mellitus by modulating postprandial blood glucose response through personalized low-glycemic dietary recommendations. Patients receive a report evaluating their meals from a previous test phase based on postprandial blood glucose response. This assessment generates dietary recommendations that, if followed, can reduce postprandial blood glucose fluctuations, positively impacting reduced insulin sensitivity, insulin resistance, and elevated blood glucose levels, thereby reducing associated symptoms. Indications: Diabetes mellitus, Type 2 (E11).
Pricing
Paid
Manufacturer price €499.80 per prescription (90 days). DiGA directory: https://diga.bfarm.de/en/verzeichnis/02090
Category
Digital Therapeutics
Tags
—
Added
Sep 2026
Conditions (ICD-10)
Categories
Pros
- Permanently listed in the German BfArM DiGA directory
- Prescribable and reimbursed by German statutory health insurance
- Therapeutic area: Hormones and Metabolism